Hi-Tech Pharmacal Co. (HITK) 43.49 $HITK
Hi-Tech Pharmacal Up 28.8% Since SmarTrend Uptrend Call (HITK)
Comtex SmarTrend(R) - Tue Feb 10, 5:13PM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 20 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
Hi-Tech Pharmacal Has Returned 28.8% Since SmarTrend Recommendation (HITK)
Comtex SmarTrend(R) - Tue Feb 03, 11:14AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 20 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
Miraculins: Pioneering a New Approach to Diabetes Screening
ACCESSWIRE - Tue Jan 27, 7:03AM CST
WINNIPEG, CA / ACCESSWIRE / January 27, 2015 / Diabetes affects nearly 30 million U.S. citizens - or roughly 10% of the population - with about 27% of those cases going undiagnosed, according to the American Diabetes Association. As well, there are approximately 80 million Americans estimated to be pre-diabetic, with 90% being completely unaware of their condition. With about 70,000 deaths in 2010 alone, diabetes is the seventh leading cause of death in the U.S. and that figure could be dramatically understated given the chronic under-diagnosis of the disease. [1] As well, diabetes and its related complications accounted for $245 billion USD in total medical costs and lost work and wages in the U.S. in 2012.[2] More than 500 million people worldwide are expected to be affected by diabetes by the year 2030, making it the 7th leading cause of death in the world. [3] [4]
LPDX: 5.24 (-0.01), MOM.VN: 0.210 (+0.005), HITK: 43.49 (-0.01)
Uptrend Call Working As Hi-Tech Pharmacal Stock Rises 28.8% (HITK)
Comtex SmarTrend(R) - Tue Jan 20, 9:24AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 19 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
Shares of HITK Up 28.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Dec 18, 11:18AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 18 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
Hi-Tech Pharmacal Shares Up 28.8% Since SmarTrend's Buy Recommendation (HITK)
Comtex SmarTrend(R) - Thu Dec 04, 9:20AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 18 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
28.8% Return Seen to Date on SmarTrend Hi-Tech Pharmacal Call (HITK)
Comtex SmarTrend(R) - Wed Nov 05, 9:19AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 17 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
Hi-Tech Pharmacal Up 28.8% Since SmarTrend Uptrend Call (HITK)
Comtex SmarTrend(R) - Tue Feb 10, 5:13PM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 20 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
Hi-Tech Pharmacal Has Returned 28.8% Since SmarTrend Recommendation (HITK)
Comtex SmarTrend(R) - Tue Feb 03, 11:14AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 20 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
Miraculins: Pioneering a New Approach to Diabetes Screening
ACCESSWIRE - Tue Jan 27, 7:03AM CST
WINNIPEG, CA / ACCESSWIRE / January 27, 2015 / Diabetes affects nearly 30 million U.S. citizens - or roughly 10% of the population - with about 27% of those cases going undiagnosed, according to the American Diabetes Association. As well, there are approximately 80 million Americans estimated to be pre-diabetic, with 90% being completely unaware of their condition. With about 70,000 deaths in 2010 alone, diabetes is the seventh leading cause of death in the U.S. and that figure could be dramatically understated given the chronic under-diagnosis of the disease. [1] As well, diabetes and its related complications accounted for $245 billion USD in total medical costs and lost work and wages in the U.S. in 2012.[2] More than 500 million people worldwide are expected to be affected by diabetes by the year 2030, making it the 7th leading cause of death in the world. [3] [4]
LPDX: 5.24 (-0.01), MOM.VN: 0.210 (+0.005), HITK: 43.49 (-0.01)
Uptrend Call Working As Hi-Tech Pharmacal Stock Rises 28.8% (HITK)
Comtex SmarTrend(R) - Tue Jan 20, 9:24AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 19 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
Shares of HITK Up 28.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Dec 18, 11:18AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 18 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
Hi-Tech Pharmacal Shares Up 28.8% Since SmarTrend's Buy Recommendation (HITK)
Comtex SmarTrend(R) - Thu Dec 04, 9:20AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 18 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
28.8% Return Seen to Date on SmarTrend Hi-Tech Pharmacal Call (HITK)
Comtex SmarTrend(R) - Wed Nov 05, 9:19AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 17 months, Hi-Tech Pharmacal has returned 28.78% as of today's recent price of $43.49.
HITK: 43.49 (-0.01)
